Disclaimer
Product Inserts on this website are made available for ilustration purposes only. When using one of our test kits, one must use the insert provided with the kit itself.
Toxoplasma gondii
Toxoplasma gondii is the contributing agent of a toxoplasmosis that occurs worldwide with high prevalence.
The development cycle of Toxoplasma gondii involves three phases:
Intestinal phase with production of sexual forms (gamogony) takes place in enterocytes of definitive hosts. Only domestic cats, and several other felid species of little epidemiological significance, can function as definitive hosts. Only extra-intestinal development is seen in intermediate hosts (pigs, sheep, and many other animal species) as well as in hosts (humans). Following the primary infection of a cat with Toxoplasma cysts in raw meat, asexual reproductive forms develop in the small intestine epithelium at first, with sexually differentiated stages and oocysts following later. The oocysts are shed in feces after prepatent period of three to nine days. When cats are infected with sporulated oocysts, the prepatent period is extended to 20-35 days. Oocyst sheeding lasts from only a few days to a maximum of three weeks, but can be highly intense.
External phase: Oocysts excreted in cat feces sporulate at room temperature within two to four days, getting them infected. Kept moist, they remain infected for up to five years and are not killed by standard disinfectant agents.
Extraintestinal phase: This phase follows a peroral ingestion with oocysts or cysts and is observed in intermediate hosts (dogs, sheep, pigs, other vertebrates, birds).
Cases are differentiated as to time of acquisition, i.e., postnatal and prenatal infections (see tab.)
Disease | Symptoms | Mechanism of Infection |
Postnatal toxoplasma infection | In general unspecific symptoms like swelling of the lymph nodes, feeling of sickness, limb pain and fever. | Oral ingestion of oocysts or cysts with food |
Reactivation toxoplasmosis | In immunosuppressed persons: encephalitis, pneumonia, myocarditis, meningoencephalitis, eye damage, generalized lymphadenitis | |
Prenatal toxoplasmosis | Infection in the first trimester of pregnancy: abortion | Prenatal infection of the fetus with toxoplasma occurs only in pregnant women with primary infection |
Infections may be diagnosed by:
- Microscopy: Determination of acute infection by coloured Giemsa or marked antibodies
- Serology: Determination of specific antibodies based on the ELISA technique
NovaLisa? Toxoplasma gondii IgG/IgM µ-capture ELISA:
The NovaLisa? Toxoplasma gondii IgG/IgM µ-capture ELISA is intended for the quantitative (IgG) and qualitative (IgM) determination of IgG-/IgM-class antibodies against Toxoplasma gondii in human serum or plasma (citrate).
Antigens:
IgG: Toxoplasma gondii (Lysate) antigens
IgM: P30
Specific performance characteristics:
Intraassay | Interasay | Sensitivity% | Specificity% | |||||
n | Mean | CV% | n | Mean | CV% | |||
IgG | 6 | 0.978 | 5.7 | 4 | 0.752 | 7.1 | 100 | 96.8 |
6 | 1.647 | 5.3 | 4 | 1.26 | 10.1 | |||
6 | 2.496 | 6.2 | 4 | 1.98 | 6.3 | |||
IgM | 20 | 0.429 | 5.6 | 12 | 13.25 | 8.8 | 95.5 | 98.2 |
20 | 1.725 | 3.2 | 11 | 48.06 | 8. | |||
NovaLisa? Toxoplasma gondii IgG Avidity Test
The avidity determination is a diagnostic method which is used to differentiate a recent (acute) and a more distant (past) infection with Toxoplasma gondii in patient sera. Avidity is the binding force of the antibody (serum specimen) with the corresponding antigen.
Low avid IgG antibodies in the early stage of infection can be differentiated from high avid antibodies associated with a past infection.
The determination of IgG antibody avidity is an additional analysis to the classic serology in regard to the status of a Toxoplasma gondii infection.
The NovaLisa? Toxoplasma gondii IgG Avidity Test is an additional reagent-kit that has to be used in combination with NovaLisa? Toxoplasma gondii IgG ELISA.
Performance Characteristics:
The NovaLisa? Toxoplasma gondii IgG Avidity Test has been evaluated for use in Toxoplasmosis with sera of acute and past infections. A total number of 69 defined patient samples were tested. These sera were supplied by the Institute of Parasitology, University Bonn.
Defined Samples | ||||
Acute Infection | Past Infection | Total | ||
Novalisa Toxoplasma gondii IgG Avidity Test | Acute Infection | 22 | 2 | 24 |
Past Infection | 3 | 42 | 45 | |
Total | 25 | 44 | 69 | |
Agreement acute infection: 88%
Agreement past infection: 95.5%
Total agreement: 92.8%
Order information:
ELISA | Number of Determinations | Product Number |
Toxoplasma IgG | 96 | TOXG0460 |
Toxoplasma IgM | 96 | TOXM0460 |
Toxoplasma IgG Avidity | 96 | TOXGA460 |
Your Partner
Customer Service





